CYBEX Launches Pink Treadmill to Support Breast Cancer Research

MEDWAY, Mass.--(BUSINESS WIRE)--Cybex International, Inc. (NASDAQ: CYBI), a leading manufacturer of premium exercise equipment for the commercial and consumer markets, announced yesterday at the Club Industry East Show in Boston, Massachusetts its introduction of the first-ever, custom-made pink treadmills to log miles and raise funds for The Breast Cancer Research Foundation (BCRF) during Breast Cancer Awareness Month - October, 2009.

“We are committed to raising funds and awareness on the benefits of exercise, particularly as it relates to improving long-term survival for those who have been treated for breast cancer”

The pink treadmills, manufactured in Medway, Massachusetts will be sold to health clubs, YMCA’s, hotels and spas, student recreation centers, corporate employee gyms and other exercise facilities around the country. CYBEX will donate 10 cents for every mile logged on any pink 750T treadmill throughout the month of October 2009 to BCRF.

Research from The Nurses Health Study published in the Journal of American Medical Association (JAMA) tracked nearly 3,000 women up to 14 years after their breast cancer diagnosis and found that exercise reduced the likelihood of breast cancer recurrence and increased the odds of living longer. Dr. Carolyn Kaelin, Harvard surgeon and author of The Breast Cancer Survivor’s Fitness Plan, explains “recurrence rates and deaths from breast cancer decreased up to 40 percent among those who exercised most, compared with those who were sedentary. Brisk walking for 3-5 hours per week – about 30 minutes a day – netted the biggest benefits.”

“We are committed to raising funds and awareness on the benefits of exercise, particularly as it relates to improving long-term survival for those who have been treated for breast cancer,” states Joan Carter, CYBEX Executive Director and Founder of the CYBEX Pink Ribbon Run. “The evolving body of research strongly suggests that, at all ages, physical activity, and in particular cardiovascular activity, reduces the risk of developing breast cancer later in life. CYBEX shares a common value with BCRF on the importance of science and research. The monies raised from this program can play an integral role in finding a cure for breast cancer.”

“The Breast Cancer Research Foundation's mission is to achieve prevention and a cure for breast cancer in our lifetime,” states Myra J. Biblowit, President of the BCRF. “Partnering with CYBEX to promote the importance of exercise is a natural synergy and underscores BCRF's mission in achieving this goal. Additionally, the monies raised can provide critical funding for innovative clinical and translational research at leading medical centers worldwide and increase public awareness about good breast health.”

“It does not need to be running a marathon, or biking a century,” notes Kaelin, “but rather simply walking briskly most days that reduces breast cancer recurrence for those who have been treated for the condition. Furthermore, for all women, in addition to physical activity optimizing body weight and reducing high blood pressure, heart disease and diabetes, scientific research is more strongly pointing to the positive effects of exercise in reducing breast cancer risk and the risks of other forms of cancer too.”

To purchase a pink treadmill or to find out if your local club is participating in the Pink Ribbon Run visit: www.cybexintl.com. NOTE TO EDITORS: For photographs, videos or more information on the CYBEX Pink Ribbon Run, contact Lynn Luczkowski [e-mail] or 860-313-1426.

About The Breast Cancer Research Foundation®

The Breast Cancer Research Foundation® was founded in 1993 by Evelyn H. Lauder as an independent, not-for-profit 501(c) (3) organization dedicated to funding innovative clinical and translational research. The Foundation supports scientists at top universities and academic medical centers worldwide conducting the most advanced and promising breast cancer research that will lead to prevention and a cure in our lifetime. A minimum of 85 cents of each dollar donated to the Foundation goes directly to breast cancer research and awareness programs. In October 2008, $34.5 million was awarded to 166 scientists across the United States and in Australia, Canada, Latin America, the Middle East, and throughout Europe. And for the eighth consecutive year, BCRF received Charity Navigator’s highest rating, four stars, thus outperforming over 99% of the evaluated charities, while the American Institute of Philanthropy has awarded BCRF its highest possible rating of A+. BCRF is the only breast cancer organization in the U.S. to receive these accolades. For more information, visit www.bcrfcure.org or call 1.866.FIND.A.CURE.

About CYBEX

Cybex International, Inc. is a leading manufacturer of premium exercise equipment for commercial and consumer use. The CYBEX product line includes a full range of both strength training and cardio training machines sold worldwide in over 85 countries under the CYBEX brand. Products are designed and engineered using exercise science to reflect the natural movement of the human body. Accommodating users from the first-time exerciser to the professional athlete, CYBEX products are available for a wide range of facilities from commercial health clubs to home gyms. For more information on CYBEX and its product lines, please visit the Company’s website at www.cybexintl.com.

This news release may contain forward-looking statements. There are a number of risks and uncertainties that could cause actual results to differ materially from those anticipated by the statements made above. These include, but are not limited to, competitive factors, technological and product developments, market demand, economic conditions, the resolution of litigation involving the Company, and the ability of the Company to comply with the terms of its credit facilities. Further information on these and other factors which could affect the Company’s financial results can be found in the Company’s previously filed Report on Form 10-K for the year ended December 31, 2008, its Reports on Form 10-Q, its Current Reports on Form 8-K, and its proxy statement dated March 26, 2009.

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=5975299&lang=en